poisar

Stocks · News reference

Adagio Medical shares are trading higher after the company announced the treatment of the first patient with its next-generation vCLAS Ultra Ultra-Low Temperature Ablation system under Expanded Access authorization from the FDA.

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Newsdesk

    Adagio Medical Holdings Q2 EPS $(0.30) Beats $(0.31) Estimate

    Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 14.29 percent increase over losses of $(0.35) per